M&A Deal Summary

Tandem Diabetes Care Acquires AMF Medical

On December 13, 2022, Tandem Diabetes Care acquired medical products company AMF Medical

Acquisition Highlights
  • This is Tandem Diabetes Care’s 2nd transaction in the Medical Products sector.
  • This is Tandem Diabetes Care’s 1st transaction in Switzerland.

M&A Deal Summary

Date 2022-12-13
Target AMF Medical
Sector Medical Products
Buyer(s) Tandem Diabetes Care
Deal Type Add-on Acquisition
Advisor(s) Leerink Partners (Financial)
Homburger (Legal)

Target

AMF Medical

Saint-Sulpice, Switzerland
AMF Medical is a developer of the Sigi™ Patch Pump. The Sigi Patch Pump is under development and not commercially available. It is designed to be an ergonomic, rechargeable patch pump that reduces the burden of managing diabetes through its use of pre-filled insulin cartridges and its compatibility with automated insulin delivery technology. AMF Medical was founded in 2014 and is based in Saint-Sulpice, Switzerland.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Tandem Diabetes Care

San Diego, California, United States

Category Company
Founded 2006
Sector Medical Products
Employees2,650
Revenue 940M USD (2024)
DESCRIPTION

Tandem Diabetes Care is a developer of medical devices for the treatment of diabetes. Tandem Diabetes Care was founded in 2006 and is based in San Diego, California.


DEAL STATS #
Overall 3 of 3
Sector: Medical Products M&A 2 of 2
Type: Add-on Acquisition M&A Deals 3 of 3
Country: Switzerland M&A 1 of 1
Year: 2022 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-07-21 Capillary Biomedical

Irvine, California, United States

Capillary Biomedical is an infusion set developer. Infusion sets provide people flexible options in insulin pump wearability. Capillary Biomedical was founded in 2014 and is based in Irvine, California.

Buy -